Table 1.
Variable | Mean (Standard Deviation)/Frequency (%) | |
---|---|---|
European-American 396 (44.1%) | African-American 502 (55.9%) | |
Age | M = 56.2 (SD= 13.0) | M =53.3 (SD= 13.4) |
Female | 267 (67.4%) | 321 (63.9%) |
Married | 233 (58.8%) | 203 (40.4%) |
Region | ||
Chicago | 243 (67.5%) | 253 (52.5%) |
Atlanta | 117 (32.5%) | 229 (47.5%) |
Education | ||
< High School | 59 (14.9%) | 198 (39.4%) |
High School/GED | 220 (55.6%) | 258 (51.4%) |
Bachelors degree | 70 (17.7%) | 29 (5.8%) |
Graduate degree | 47 (12.9%) | 17 (3.4%) |
High Literacy | 346 (94.0%) | 339 (77.8%) |
Diagnosis | ||
Breast cancer | 195 (49.2%) | 195 (38.8%) |
Colon cancer | 27 (6.8%) | 86 (17.1%) |
Head/Neck Cancer | 28 (7.1%) | 45 (9.0%) |
Lung Cancer | 103 (26.0%) | 107 (21.3%) |
AIDS-related malignancies | 43 (10.9%) | 69 (13.7%) |
No Current Insurance | 44 (11.8%) | 123 (27.8%) |
Performance Status | ||
Normal activity | 168 (42.5%) | 190 (37.9%) |
Some symptoms | 125 (31.6%) | 156 (31.1%) |
Bed rest < 50% of day | 82 (20.8%) | 107 (21.4%) |
Bed rest > 50% of day | 20 (5.1%) | 48 (9.6%) |
Extent of Disease | ||
No evidence of disease | 150 (40.7%) | 124 (28.0%) |
Local Disease | 60 (16.3%) | 105 (23.7%) |
Regional Spread | 58 (15.7%) | 110 (24.8%) |
Distant metastases | 101 (27.4%) | 104 (23.5%) |
Currently on active treatmenta | ||
Yes | 33 (8.3%) | 54 (10.8%) |
FACT-G Subscale Scores | ||
Physical Well-Being | M= 21.7 (SD= 5.6) | M= 20.2 (SD= 6.0) |
Social Well-Being | M= 23.0 (SD= 4.8) | M= 20.9 (SD= 5.7) |
Emotional Well-Being | M= 18.2 (SD= 4.5) | M= 18.8 (SD= 5.2) |
Functional Well-Being | M= 19.6 (SD= 6.3) | M= 18.1 (SD= 7.1) |
Active treatment is defined as chemotherapy, radiotherapy, or antiretroviral therapy. Participants not on active treatment may have been on other medications that are not considered “active,” such as hormonal or analgesic medication.